DXCM

DexCom, Inc. DXCM

$76.65 -1.33 (-1.71%)

Extended · +1.22σ

+ Compare Open in Sniper

Mkt cap $28.6B

P/E 33.2

Day $75.95 – $78.01

52wk $56.72 – $79.15

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

DexCom, Inc. is a healthcare company listed in the US.

DXCM last traded at $76.65, down 1.7% on the day; that's in the upper part of its 52-week range ($56.72–$79.15). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $88.64 (fair range $36–$89); today's price leaves a +13% cushion below that estimate. The model's verdict is “Undervalued” and accounting quality screens as Strong. Model estimates only — do your own due diligence.

Intrinsic (DCF)

$88.64

Fair-value range

$36.25 – $88.64

Margin of safety

+13%

Verdict

Undervalued

Accounting quality Strong

✓ More cash than debt
✓ Quick ratio 1.69 (antifragile)
✓ Goodwill 0% of assets (organic growth)
✓ Positive retained earnings

⚠ Receivables growing faster than revenue

Price implies ~13% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

DXCM is a $28.6 billion company, priced at 33× last year's earnings, and the stock is trading near the top of its 52-week range.

Mkt cap $28.6B

P/E ttm 33.2

Fwd P/E —

Beta —

Day range $75.95 – $78.01

52w range $56.72 – $79.15

Avg vol —

RSI(2) 58.5

ROE —

Net mgn —

FCF mgn 22.7%

Debt/Eq 0.47

Div yld —

Sector Healthcare

Industry Medical Devices

Next earn —

52-week range · today's price

$56.72$79.15